P1521: A SEVERE MOUSE MODEL OF ALPHA-THALASSEMIA SHOWS ABNORMAL IRON METABOLISM, ERYTHROPOIESIS AND COAGULATION, AND CAN BE RESCUED BY A NOVEL GENE THERAPY APPROACH
Stefano Rivella(Children's Hospital of Philadelphia), Osheiza Abdulmalik(Children's Hospital of Philadelphia), Amaliris Guerra(Children's Hospital of Philadelphia), Stavros Glentis, Valentina Ghiaccio(Children's Hospital of Philadelphia), Michael Triebwasser(University of Michigan), Laura Breda(Children's Hospital of Philadelphia), Maxwell Chappell(Children's Hospital of Philadelphia), Kandace Gollomp(Children's Hospital of Philadelphia), Nattiya Teawtrakul(Khon Kaen University), Megan Fedorky(Children's Hospital of Philadelphia), Antonios Kattamis, Danuta Jarocha(Jagiellonian University)
Cited by 1
Related Papers
In vivo hematopoietic stem cell modification by mRNA delivery
|Science|2023|321
5‐hydroxymethyl‐2‐furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells<sup>†,‡</sup>
|British Journal of Haematology|2005|244
Domain-focused CRISPR screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells
|Science|2018|159
Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression
|Journal of Clinical Investigation|2014|125
Investigating the magnetic susceptibility properties of fresh human blood for noninvasive oxygen saturation quantification
|Magnetic Resonance in Medicine|2011|115